pirtobrutinib 50 MG Oral Tablet

RxCUI: 2629351
RxNorm name: pirtobrutinib 50 MG Oral Tablet
Display name: pirtobrutinib 50 MG Oral Tablet
Full name: pirtobrutinib 50 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
JAYPIRCA	PIRTOBRUTINIB	Eli Lilly and Company	bd551845-0878-49a4-860f-839b83f6b801	2026-03-06	Warnings, Adverse reactions	Exact identifier rxcui: 2629351

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
bd551845-0878-49a4-860f-839b83f6b801	pirtobrutinib 50 MG Oral Tablet [PSN] · pirtobrutinib 50 MG Oral Tablet [SCD]	2	14	These highlights do not include all the information needed to use JAYPIRCA safely and effectively. See full prescribing information for JAYPIRCA. JAYPIRCA ® (pirtobrutinib) tablets, for oral use Initial U.S. Approval: 2023	20260306